G-rich proto-oncogenes are targeted for genomic instability in B-cell lymphomas

被引:56
作者
Duquette, Michelle L.
Huber, Michael D.
Maizels, Nancy
机构
[1] Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA
[2] Univ Washington, Sch Med, Dept Biochem, Seattle, WA 98195 USA
关键词
D O I
10.1158/0008-5472.CAN-06-2419
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Diffuse large B-cell lymphoma is the most common lymphoid malignancy in adults. It is a heterogeneous disease with variability in outcome. Genomic instability of a subset of proto-oncogenes, including c-MYC, BCL6, RhoH, PIM1, and PAX5, can contribute to initial tumor development and has been correlated with poor prognosis and aggressive tumor growth. Lymphomas in which these proto-oncogenes are unstable derive from germinal center B cells that express activation-induced deaminase (AID), the B-cell-specific factor that deaminates DNA to initiate immunoglobulin gene diversification. Proto-oncogene instability is evident as both aberrant hypermutation and translocation, paralleling programmed instability which diversifies the immunoglobulin loci. We have asked if genomic sequence correlates with instability in AID-positive B-cell lymphomas. We show that instability does not correlate with enrichment of the WRC sequence motif that is the consensus for deamination by AID. Instability does correlate with G-richness, evident as multiple runs of the base guanine on the nontemplate DNA strand. Extending previous analysis of c-MYC, we show experimentally that transcription of BCL6 and RhoH induces formation of structures, G-loops, which contain single-stranded regions targeted by AID. We further show that G-richness does not characterize translocation breakpoints in AID-negative B- and T-cell malignancies. These results identify G-richness as one feature of genomic structure that can contribute to genomic instability in AID-positive B-cell malignancies.
引用
收藏
页码:2586 / 2594
页数:9
相关论文
共 50 条
[1]   BCL6 gene translocation in follicular lymphoma:: a harbinger of eventual transformation to diffuse aggressive lymphoma [J].
Akasaka, T ;
Lossos, IS ;
Levy, R .
BLOOD, 2003, 102 (04) :1443-1448
[2]   Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling [J].
Alizadeh, AA ;
Eisen, MB ;
Davis, RE ;
Ma, C ;
Lossos, IS ;
Rosenwald, A ;
Boldrick, JG ;
Sabet, H ;
Tran, T ;
Yu, X ;
Powell, JI ;
Yang, LM ;
Marti, GE ;
Moore, T ;
Hudson, J ;
Lu, LS ;
Lewis, DB ;
Tibshirani, R ;
Sherlock, G ;
Chan, WC ;
Greiner, TC ;
Weisenburger, DD ;
Armitage, JO ;
Warnke, R ;
Levy, R ;
Wilson, W ;
Grever, MR ;
Byrd, JC ;
Botstein, D ;
Brown, PO ;
Staudt, LM .
NATURE, 2000, 403 (6769) :503-511
[3]   Rearrangements of the c-myc oncogene are present in 15% of primary human multiple myeloma tumors [J].
Avet-Loiseau, H ;
Gerson, F ;
Magrangeas, F ;
Minvielle, S ;
Harousseau, JL ;
Bataille, R .
BLOOD, 2001, 98 (10) :3082-3086
[4]   Chromosome translocations in multiple myeloma [J].
Bergsagel, PL ;
Kuehl, WM .
ONCOGENE, 2001, 20 (40) :5611-5622
[5]  
Bhatia K, 1995, Curr Top Microbiol Immunol, V194, P389
[6]   BCL-6 and other genomic alterations in non-Hodgkin's lymphoma (NHL) [J].
Butler, M ;
Corbally, N ;
Dervan, PA ;
Carney, DN .
BRITISH JOURNAL OF CANCER, 1997, 75 (11) :1641-1645
[7]  
Capello D, 2000, BLOOD, V95, P651
[8]   Transcription-targeted DNA deamination by the AID antibody diversification enzyme [J].
Chaudhuri, J ;
Tian, M ;
Khuong, C ;
Chua, K ;
Pinaud, E ;
Alt, FW .
NATURE, 2003, 422 (6933) :726-730
[9]  
DALLERY E, 1995, ONCOGENE, V10, P2171
[10]   AID binds to transcription-induced structures in c-MYC that map to regions associated with translocation and hypermutation [J].
Duquette, ML ;
Pham, P ;
Goodman, MF ;
Maizels, N .
ONCOGENE, 2005, 24 (38) :5791-5798